Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future
- 14 March 2020
- journal article
- review article
- Published by Taylor & Francis Ltd in Hospital Practice
- Vol. 48 (2), 51-67
- https://doi.org/10.1080/21548331.2020.1745509
Abstract
Currently about 19 million people in Africa are known to be living with diabetes, mainly Type 2 diabetes (T2DM) (95%), estimated to grow to 47 million people by 2045. However, there are concerns with early diagnosis of patients with Type 1 diabetes (T1DM) as often patients present late with complications. There are also challenges with access and affordability of insulin, monitoring equipment and test strips with typically high patient co-payments, which can be catastrophic for families. These challenges negatively impact on the quality of care of patients with T1DM increasing morbidity and mortality. There are also issues of patient education and psychosocial support adversely affecting patients’ quality of life. These challenges need to be debated and potential future activities discussed to improve the future care of patients with T1DM across Africa. Documentation of the current situation across Africa for patients with T1DM including the epidemiology, economics, and available treatments within public healthcare systems as well as ongoing activities to improve their future care. Subsequently, provide guidance to all key stakeholder groups going forward utilizing input from senior-level government, academic and other professionals from across Africa. Whilst prevalence rates for T1DM are considerably lower than T2DM, there are concerns with late diagnosis as well as the routine provision of insulin and monitoring equipment across Africa. High patient co-payments exacerbate the situation. However, there are ongoing developments to address the multiple challenges including the instigation of universal health care and partnerships with non-governmental organizations, patient organizations, and pharmaceutical companies. Their impact though remains to be seen. In the meantime, a range of activities has been documented for all key stakeholder groups to improve future care. There are concerns with the management of patients with T1DM across Africa. A number of activities has been suggested to address this and will be monitored.Keywords
This publication has 101 references indexed in Scilit:
- Ketoacidosis at diagnosis of type 1 diabetes in children and adolescents: frequency and clinical characteristicsJournal of Diabetes & Metabolic Disorders, 2013
- Insulin use, prescription patterns, regimens and costs.-a narrative from a developing countryDiabetology & Metabolic Syndrome, 2012
- Diabetes in Sub Saharan Africa 1999-2011: Epidemiology and public health implications. a systematic reviewBMC Public Health, 2011
- Evaluation of the incremental cost to the National Health Service of prescribing analogue insulinBMJ Open, 2011
- The prevalence and incidence of and risk factors for, micro-albuminuria among urban Africans with type 1 diabetes in South Africa: An inter-ethnic studyInternational Journal of Diabetes Mellitus, 2010
- Hyperglycemic Crises in Adult Patients With DiabetesDiabetes Care, 2009
- Long‐acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta‐analysisDiabetes, Obesity and Metabolism, 2009
- Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysisCMAJ : Canadian Medical Association Journal, 2009
- An Assessment of the Disease Burden of Foot Ulcers in Patients With Diabetes Mellitus Attending a Teaching Hospital in Lagos, NigeriaThe International Journal of Lower Extremity Wounds, 2006
- Toll‐like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetesTissue Antigens, 2005